Sunflower Pharmaceutical Appoints Liu Junfeng as Deputy General Manager

财中社··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Sunflower Pharmaceutical announced the appointment of Liu Junfeng as the company's deputy general manager, with a term lasting until the end of the current board's tenure. Liu Junfeng previously served as office director of the R&D center and deputy director of the natural medicine laboratory at Luye Pharma Group, executive deputy general manager of Shandong Target Drug Research, senior vice president of KPC Pharmaceuticals, and deputy general manager of the company. In the first quarter of 2026, Sunflower Pharmaceutical achieved revenue of 844 million yuan and net profit attributable to the parent company of 110 million yuan.

Impact on assets 3

Biotech & Genomic Medicine▲ · 1 stocks
Others▲ · 2 stocks